REOLYSIN
Sponsors
Oncolytics Biotech, Canadian Cancer Trials Group, University of Leeds
Conditions
Cancer of SkinCarcinoma, Squamous Cell of the Head and NeckMelanomaMetastatic Breast CancerMetastatic MelanomaMetastatic Pancreatic AdenocarcinomaMetastatic or Recurrent Squamous Cell Carcinoma of the LungMultiple Myeloma
Phase 1
Phase 2
Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
CompletedNCT00984464
Start: 2009-09-30End: 2014-10-31Updated: 2015-04-10
A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma
CompletedNCT00998322
Start: 2009-10-31End: 2015-02-28Updated: 2015-04-10
A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung
CompletedNCT00998192
Start: 2009-10-31End: 2015-08-31Updated: 2016-03-31
A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer
CompletedNCT01656538
Start: 2013-02-20End: 2018-02-14Updated: 2023-08-04